These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 21464252

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors.
    Komeda T, Ishii S, Itoh Y, Sanekata M, Yoshikawa T, Shimada J.
    J Infect Chemother; 2016 Oct; 22(10):677-84. PubMed ID: 27497712
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of clinical pharmacology in supporting the emergency use authorization of an unapproved anti-influenza drug, peramivir.
    Arya V, Carter WW, Robertson SM.
    Clin Pharmacol Ther; 2010 Nov; 88(5):587-9. PubMed ID: 20959843
    [Abstract] [Full Text] [Related]

  • 9. Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variants.
    Sato M, Ito M, Suzuki S, Sakuma H, Takeyama A, Oda S, Watanabe M, Hashimoto K, Miyazaki K, Kawasaki Y, Hosoya M.
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1643-9. PubMed ID: 25547357
    [Abstract] [Full Text] [Related]

  • 10. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.
    Hernandez JE, Adiga R, Armstrong R, Bazan J, Bonilla H, Bradley J, Dretler R, Ison MG, Mangino JE, Maroushek S, Shetty AK, Wald A, Ziebold C, Elder J, Hollister AS, Sheridan W, eIND Peramivir Investigators.
    Clin Infect Dis; 2011 Mar 15; 52(6):695-706. PubMed ID: 21367722
    [Abstract] [Full Text] [Related]

  • 11. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza.
    Mancuso CE, Gabay MP, Steinke LM, Vanosdol SJ.
    Ann Pharmacother; 2010 Mar 15; 44(7-8):1240-9. PubMed ID: 20516360
    [Abstract] [Full Text] [Related]

  • 12. Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir.
    Renaud C, Pergam SA, Polyak C, Jain R, Kuypers J, Englund JA, Corey L, Boeckh MJ.
    Transpl Infect Dis; 2010 Dec 15; 12(6):513-7. PubMed ID: 21062390
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Peramivir for the treatment of influenza.
    Shetty AK, Peek LA.
    Expert Rev Anti Infect Ther; 2012 Feb 15; 10(2):123-43. PubMed ID: 22339187
    [Abstract] [Full Text] [Related]

  • 16. Response to several recent publications related to safety and efficacy of peramivir from the emergency use authorization experience.
    Ison MG, Hollister AS, Sheridan WP.
    Clin Infect Dis; 2013 Jan 15; 56(1):164. PubMed ID: 22972863
    [No Abstract] [Full Text] [Related]

  • 17. Postpartum pharmacokinetics of peramivir in the treatment of 2009 H1N1 influenza.
    Clay PG, Adiga RB, Taylor TAH, Alsup R, Gerk PM, McRae M.
    Obstet Gynecol; 2011 Aug 15; 118(2 Pt 2):463-467. PubMed ID: 21768855
    [Abstract] [Full Text] [Related]

  • 18. Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. II: a pediatric drug use investigation.
    Komeda T, Ishii S, Itoh Y, Ariyasu Y, Sanekata M, Yoshikawa T, Shimada J.
    J Infect Chemother; 2015 Mar 15; 21(3):194-201. PubMed ID: 25523716
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of peramivir for influenza treatment.
    Hata A, Akashi-Ueda R, Takamatsu K, Matsumura T.
    Drug Des Devel Ther; 2014 Mar 15; 8():2017-38. PubMed ID: 25368514
    [Abstract] [Full Text] [Related]

  • 20. Intravenous peramivir for treatment of influenza in hospitalized patients.
    Ison MG, Fraiz J, Heller B, Jauregui L, Mills G, O'Riordan W, O'Neil B, Playford EG, Rolf JD, Sada-Diaz E, Elder J, Collis P, Hernandez JE, Sheridan WP.
    Antivir Ther; 2014 Mar 15; 19(4):349-61. PubMed ID: 23985625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.